Table of Content


Introduction
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Overview
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Therapeutics Development
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Therapeutics Assessment
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Companies Involved in Therapeutics Development
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Drug Profiles
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Dormant Projects
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Discontinued Products
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Product Development Milestones
Appendix



List of Figures

List of Figures
Number of Products under Development for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by Applied Genetic Technologies Corp, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by Ashvattha Therapeutics LLC, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by Autobahn Therapeutics Inc, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by bluebird bio Inc, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by Celularity Inc, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by Imstem Biotechnology Inc, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by MedDay SA, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by Minoryx Therapeutics sl, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by NeuroVia Inc, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by Orpheris Inc, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by Poxel SA, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by SwanBio Therapeutics Ltd, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Pipeline by Viking Therapeutics Inc, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Dormant Projects, 2021
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) - Discontinued Products, 2021